gerd tirzepatide and Acid Reflux: Managing GI Side Effects S643 Assessing Risk of Gastroesophageal

These patterns position the result as a biologically coherent signal that warrants prospective testing. Reflecting on what it might be about GLP-1 drugs that allow them to potentially help lower a persons colon cancer risk, Cuomo said that any of the same pathways relevant to postdiagnosis outcomes could also reduce carcinogenesis or cancer progression

In rare cases, more serious reactions may occur

Read the full narrative on Hims & Hers Health (it's free!) Hims & Hers Health's narrative projects $3.6 billion revenue and $248.5 million earnings by 2029

That means the GLP-1 contenders could make the landscape very different in just a couple of years